Newsletters
The Regulation Digest
A weekly compendium of regulatory policy, news and analysis.
"The Regulation Digest is better than an algorithm."
Dr. Roslyn Layton
Visiting Scholar, American Enterprise Institute
This Week's Edition
In this edition: EPA proposes enforceable levels of PFAS “forever chemicals” for drinking water. EPA issues the final rule on its ‘Good Neighbor’ plan for reducing smog from fossil-fuel fired power plants. FDA updates mammography standards to require patient notifications about tissue density. REAL ID enforcement deadline extended. Plus news & analysis on bank failures, cyber strategy, and more.
"I recommend everyone subscribe to the Regulation Digest. It's really indispensable."
Adam White
Executive Director, Center for the Study of the Administrative State
Previous Editions of Regulation Digest
- March 8, 2023
-
Read our latest Digest for info on EPA affirming its ‘Appropriate and Necessary’ finding, new cybersecurity regulations unveiled, USDA's draft 'Made in the USA' food label requirements. Plus, Biden's first veto anticipated, and a roundup of the week's regulation news and commentary.
- March 1, 2023
-
This week: EPA to consider health risks of phthalates cumulatively, USDA to enable online ordering & delivery for WIC nutrition program, and SCOTUS hears cases on CFPB funding & student loan forgiveness. Plus, states sue FDA over access to abortion pill, commentary on AI regulation, and roundup of news & analysis.
- February 22, 2023
-
Read the latest Digest newsletter for details of the proposed DHS restrictions on asylum, new White House executive order builds on racial equity plans, Virginia rolls out its state-level OIRA. Plus commentary, analysis, and the weekly roundup of regulation news.
- February 15, 2023
-
Read the latest Regulation Digest newsletter for details on HUD’s proposed fair housing updates, SAMHSA’s plan to nix the ‘X-waiver’ for opioid disorder treatments, and an FTC commissioner resigns. Plus notable actions from the Social Security Administration, the Administration for Children and Families, and a roundup of the past week's regulatory news and analysis.
- February 8, 2023
-
Read the latest newsletter for details on the White House plan to rescind the moral exception to contraception coverage under the Affordable Care Act. USDA aims to reduce sugar and sodium in school meals. OIRA advances its efforts to broaden public participation in rulemaking. Notable actions by SEC, OPM, ED, CBP. Plus, a roundup of this week’s regulation news and commentary.
- February 1, 2023
-
Read the latest Regulation Digest newsletter for info on FDA’s plans to reorganize. EPA revisits air quality standards for particulate matter and proposes a new use rule on PFAS. Notable actions from the Centers for Medicare and Medicaid, Department of Energy, and USDA Forest Service. Plus a roundup of this week’s regulatory news and commentary.
- January 25, 2023
-
Read the latest newsletter for details on USDA’s tougher enforcement of organic labeling, a proposal from FCC to prevent digital discrimination in broadband access, and updated EPA emission standards for new heavy-duty vehicles. White House unveils blueprint for a Renter’s Bill of Rights. Plus a roundup of this week’s regulatory news and commentary. And don’t miss our Year In Review of top regulatory trends for 2022!
- January 18, 2023
-
Read our latest Digest for potential controversy surrounding gas stoves: a danger in need of intervention or an overreach in the making? New scope announced for Waters of the United States governed by the Clean Water Act. Notable actions by Dept of Veterans Affairs and Federal Aviation Administration. A coordinated proposal on faith-based partnerships is floated by a wide array of agencies. Plus a roundup of this week’s regulatory news and commentary. And don’t miss our GW Reg Studies podcast on implications of ChatGPT for regulatory notice and comment!
- January 11, 2023
-
Read the latest newsletter for details on the FTC proposal banning noncompete clauses in employment contracts, EPA’s plan strengthening Air Quality Standards, and ED restructuring of income-driven student loan repayment programs. Notable actions from USDA and HHS. Plus the full rundown of regulatory news and analysis from Axios, WSJ, NY Times, Washington Post, and more.
- January 4, 2023
-
Read the latest issue of Regulation Digest for details on the Biden Administration’s Fall 2022 Unified Agenda and new Open Government action plan. Notable items from EPA, DHS, TSA, FTC, FDA, and Treasury. Plus the rundown of regulatory news and commentary you need for a good start to 2023!
The Regulatory Studies Center Update
A monthly(ish) collection of working papers, events, op-eds and insights.
Subscribe to the Monthly Bulletin
Latest Edition
This update featured a Minnesota Law Review Article by Bridget Dooling and Laura Stanley: Extending Pandemic Flexibilities for Opioid Use Disorder Treatment.
Susan Dudley co-authored an op-ed with Sally Katzen for RealClear Policy, "Senators Working Across the Aisle for Better Regulation."
There are also insights by Zhoudan Xie on regulatory uncertainty, Daniel Pérez on a recent draft ACUS report to improve the Congressional Review Act, Bridget Dooling on the Benefits of Rowdy Bureacracy and the OSHA vaccine mandate, and Laura Stanley on interim-final rules. Plus commentaries by our graduate students Timberley Thompson and Dylan Desjardins on distributional language in executive orders and a new report by the OECD on agile regulation.
Previous Editions of the Regulatory Studies Center Update
- July 2021
-
This update features a recent report by co-authored by Steve Balla and Bridget Dooling Mass, Computer-Generated, and Fraudulent Comments, for the Administrative Conference of the United States. Dooling and Balla also joined Susan Dudley on the GW Trachtenberg School's summer conversation series to discuss the report and more: Mass, Bots, and Fake Comments on Rulemaking.
The update also includes research by Tara Sinclair and Zhoudan Xie on Sentiment and Uncertainty about Regulation, Mark Febrizio and Kekai Liu on The Frequency of Regulatory Suspensions in the 21st Century, commentary on President Biden's executive order on competition, distributional effects in regulatory impact analysis, equity in rulemaking, agency guidance documents, and antitrust enforcement.
Also featured is Bridget Dooling's selection by the Administrative Conference of the United States to work with Rachel Potter from the University of Virginia to study the use of contractors in the rulemaking process.Plus various op-eds in Slate and Forbes, events with the Regulatory Transparency Project, Case Western University, Women in Government Relations, Environmental Protection Agency, and the ABA's AdLaw Section. Plus quotes in popular media outlets, including the Los Angeles Times, The Hill, and Yahoo.
- May 2021
-
This update features our recent report by Bridget Dooling and Laura Stanley Unsupervised Use of Opioid Treatment Medications, which is the second part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project. It also includes a Congressional testimony by Howard Beales, and analysis of the Congressional Review Act by Daniel Pérez, President Biden's actions to undo Trump administration rulemaking by Mark Febrizio, and a report to the Administrative Conference of the United States by Steve Balla and Bridget Dooling.
Also featured is Bridget Dooling's appearance on the GovActually podcast with Princeton University professor Martha Coven to discuss being a part of the Biden Transition Team.Plus various op-eds in the The Philadelphia Inquirer and Forbes, events with ABA AdLaw Section, Society for Benefit-Cost Analysis, Environmental Law Institute, Midwest Political Science Assocation, and the GW Economics Department, and quotes in popular media outlets, including The Wall Street Journal, NPR, Government Executive, Daily Beast, Marketplace, and Axios.
- March 2021
-
This update features our recent report by Bridget Dooling and Laura Stanley Telemedicine & Initiating Buprenorphine Treatment, which is part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project. It also includes scholarly articles by Susan Dudley on President Biden's early executive actions, Jerry Ellig on surface freight deregulation, and Bridget Dooling on GAO's role in the administrative state and her innovative research on bespoke regulatory review.
There is also an analysis of regulatory sentiment by Zhoudan Xie, a reflection on the year that was 2020 by Mark Febrizioi and Zhoudan Xie, opioid treatment waivers by Laura Stanley, and advice for the Biden-Harris administration from Richard J. Pierce, Jr. and Susan Dudley.Plus various op-eds in the Wall Street Journal, The Hill, Forbes, and Government Executive, events with American Economic Association, Federalist Society, and Southern Economic Association, and quotes in popular media outlets, including the Wall Street Journal, Federal News Network, Science, Bloomberg, USA Today, and Axios.
- November 2020
-
This update features our recent Delivering the Goods event with analysis from STB general counsel Craig Keats and UW-Milwaukee professor James Peoples, and includes scholarly articles by Bridget Dooling on the Administrative Procedure Act, Brian Mannix on the EPA's 50th anniversary, and Aryamala Prasad & Daniel Pérez on the effects of GDPR.
There is also an analysis of FCC spectrum auctions by Gerald Brock, and public interest comments related to immigration policies from DHS by Mark Febrizio, OPM's paid parental leave by Joseph Cordes & Jerry Ellig, and a Section 230 petition by Jerry Ellig.Plus various commentaries, op-eds, and quotes in popular media outlets, including the Wall Street Journal, New York Times, The Hill, Bloomberg, Forbes, Politico, Reuters, Audubon Magazine, Government Executive, and Law360.
- August 2020
-
This update includes scholarly articles by Susan Dudley on the durability of OIRA's regulatory oversight, Bridget Dooling on a new concept for independent agency rulemaking called Bespoke Regulatory Review, Jerry Ellig on how to improve economic analysis at federal agencies, and Zhoudan Xie's review of regulations and news coverage during the COVID-19 pandemic.
There are also public interest comments on a recent EPA proposal by Brian Mannix and Joe Cordes, a review of the Spring Unified Agenda by Daniel Pérez, and Mark Febrizio provides a full analysis of the Trump Administration's regulatory budget.Plus various commentaries, op-eds, and quotes in popular media outlets, including the New York Times, The Hill, Bloomberg, Forbes, Politifact, and Vox.